Study reveals a five-year biochemical recurrence-free survival rate of 73.4%.
The best outcomes in terms of biochemical disease-free survival are achieved with earlier referral for salvage therapy.
Framework for optimizing treatment should involve joint management by urologist, medical oncologist
Study findings suggest adiposity may carry a risk for cancers beyond those identified as obesity-related by the National Cancer Institute.
ERG in biopsied prostate tissue indicates a higher likelihood of a prostate cancer diagnosis.
Long-term treatment led to a decrease in Crohn's Disease Activity Index and high-sensitivity C-reactive protein.
Slight shrinkage occurs early after radical prostatectomy, but by six months, the length returns to what it was before surgery.
Tasquinimod found to improve symptomatic progression, especially among patients with bone metastases.
Template-guided saturation prostate biopsies are no longer necessary when high-quality state-of- the-art mpMRI is available
Predisposing factors include a history of infection and prior abdominal surgery.
Men with a history of prostate cancer are at increased risk of melanoma.
Twelve weeks of Qigong relieved fatigue and distress, researchers report.
About 30 percent of men experience an AUA symptoms index improvement of 3 or more points.
Midrange levels of total testosterone and dihydrotestosterone are associated with decreased all-cause mortality.
The drug combination was associated with significantly improved erectile function and partner satisfaction in men who did not respond to testosterone alone.